Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1100 of 1294 entries
View as:
Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A Subjects
Phase: N/A
Priority: Normal
Start: 03/31/09
End: 10/31/09
Due: 10/31/10
Phase: N/A
Priority: Normal
Start: 01/31/07
End: 03/31/09
Due: 03/31/10
Phase: N/A
Priority: Normal
Start: 01/31/09
End: 04/30/09
Due: 04/30/10
Phase: N/A
Priority: Normal
Start: 01/31/08
End: 02/28/09
Due: 02/28/10
Phase: N/A
Priority: Normal
Start: 03/10/03
End: 03/22/04
Due: 03/22/05
Phase: N/A
Priority: Normal
Start: 08/03/21
End: 06/20/22
Due: 06/20/23
Phase: N/A
Priority: Normal
Start: 03/31/03
End: 10/31/03
Due: 10/31/04
Phase: N/A
Priority: Normal
Start: 06/02/25
End: 05/03/28
Due: 05/03/29
Phase: N/A
Priority: Normal
Start: 12/21/23
End: 09/30/24
Due: 09/30/25
Phase: N/A
Priority: Normal
Start: 02/28/09
End: 05/31/10
Due: 05/31/11
Phase: N/A
Priority: Normal
Start: 04/30/11
End: 08/31/11
Due: 08/31/12
Phase: N/A
Priority: Normal
Start: 07/23/98
End: 07/26/04
Due: 07/26/05
Phase: N/A
Priority: Normal
Start: 01/05/14
End: 01/11/16
Due: 01/11/17
Phase: N/A
Priority: Normal
Start: 01/10/07
End: 03/11/08
Due: 03/11/09
Phase: N/A
Priority: Normal
Start: 07/31/04
End: 03/31/05
Due: 03/31/06
Phase: N/A
Priority: Normal
Start: 01/15/21
End: 03/08/23
Due: 03/08/24
Phase: N/A
Priority: Normal
Start: 10/05/15
End: 05/14/18
Due: 05/14/19
Phase: N/A
Priority: Normal
Start: 01/20/21
End: 06/28/22
Due: 06/28/23
Phase: N/A
Priority: Normal
Start: 08/11/22
End: 10/12/22
Due: 10/12/23
Phase: N/A
Priority: Normal
Start: 10/31/05
End: 11/30/05
Due: 11/30/06
Phase: N/A
Priority: Normal
Start: 03/18/07
End: 10/09/18
Due: 10/09/19
Phase: N/A
Priority: Normal
Start: 12/18/23
End: 12/30/24
Due: 12/30/25
Phase: N/A
Priority: Normal
Start: 07/29/19
End: 10/27/21
Due: 10/27/22
Phase: N/A
Priority: Normal
Start: 11/30/10
End: 04/30/12
Due: 04/30/13
Phase: N/A
Priority: Normal
Start: 10/31/10
End: 03/31/11
Due: 03/31/12